Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography

Japanese Journal of Ophthalmology

Volumn 55, Issue 1, 2011, Pages 1-6

  Yamamoto, Motoshi ^a   Nishijima, Kazuaki ^a   Nakamura, Misako ^a   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

central serous chorioretinopathy; inner retinal thickness; spectral domain optical coherence tomography; Vogt Koyanagi Harada disease

Indexed keywords

FLUORESCEIN; MEPREDNISONE; PREDNISOLONE;

ACUTE DISEASE; ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; EYE EXAMINATION; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATIENT MONITORING; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA INNER PLEXIFORM LAYER; RETINA THICKNESS; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STRUCTURE ANALYSIS; VISUAL SYSTEM PARAMETERS; VOGT KOYANAGI SYNDROME;

ACUTE DISEASE; ADULT; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INFUSIONS, INTRAVENOUS; LASER COAGULATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 79952306835     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0900-3     Document Type: Article

References (9)

1. N.A. Rao S. Sukavatcharin J.H. Tsai 2007 Vogt-Koyanagi-Harada disease diagnostic criteria Int Ophthalmol 27 195 199 10.1007/s10792-006-9021-x 17384920 (Pubitemid 46909261)
2. R.W. Read G.N. Holland N.A. Rao, et al. 2001 Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature Am J Ophthalmol 131 647 652 1:STN:280:DC%2BD3M3ovVynsw%3D%3D 10.1016/S0002-9394(01)00925-4 11336942 (Pubitemid 32422124)
3. R.S. Moorthy H. Inomata N.A. Rao 1995 Vogt-Koyanagi-Harada syndrome Surv Ophthalmol 39 265 292 1:STN:280:DyaK2M3kt1ahtA%3D%3D 10.1016/S0039-6257(05) 80105-5 7725227
4. S. Sugita H. Takase C. Taguchi, et al. 2006 Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens Invest Ophthalmol Vis Sci 47 2547 2554 10.1167/iovs.05-1547 16723469 (Pubitemid 351639840)
5. F.M. Damico E. Cunha-Neto A.C. Goldberg, et al. 2005 T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis Invest Ophthalmol Vis Sci 46 2465 2471 10.1167/iovs.04-1273 15980237 (Pubitemid 43119495)
6. L. Arellanes-García M. Hernández-Barrios J. Fromow-Guerra, et al. 2007 Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome Int Ophthalmol 27 155 161 10.1007/s10792-006-9027-4 17253110 (Pubitemid 46909256)
7. A.A. Okada T. Mizusawa J. Sakai, et al. 1998 Videofundoscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome Br J Ophthalmol 82 1175 1181 1:STN:280:DyaK1M7itlersA%3D%3D 10.1136/bjo.82.10.1175 9924307
8. N.A. Rao 2007 Pathology of Vogt-Koyanagi-Harada disease Int Ophthalmol 27 81 85 10.1007/s10792-006-9029-2 17435969 (Pubitemid 46909246)
9. K. Ishihara M. Hangai M. Kita, et al. 2009 Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography Ophthalmology 116 1799 1807 10.1016/j.ophtha.2009.04.002 19643489